Selank
Anxiolytic Nootropic Peptide
Selank is a synthetic analogue of tuftsin, an immunomodulatory peptide derived from IgG. Developed in Russia as an anxiolytic, it has been studied both for anxiety and PTSD models and for its unusual dual role affecting both mood regulation and immune function — a combination that sets it apart from most anxiolytic compounds.
At a Glance
Selank's mechanism involves multiple pathways simultaneously. It modulates GABA-A receptor activity (the same receptor family targeted by benzodiazepines), influences enkephalin metabolism, and has demonstrated direct effects on immune cell activity — a rare combination in a single peptide.
Unlike benzodiazepines, Selank does not produce sedation, dependence, or cognitive impairment — its anxiolytic effect is described as clean anxiety reduction with maintained alertness, which has made it a useful research tool for separating anxiolytic activity from sedative effects.
Its tuftsin-derived immunomodulatory properties add a secondary research dimension — immune cells express receptors for tuftsin, and Selank's effects on NK cell activity and cytokine balance have been studied independently of its cognitive applications.
This compound operates through several converging biological pathways, which helps explain the breadth of effects observed across different tissue and metabolic models.
GABA-A Modulation
Modulates GABA-A receptor activity to reduce anxiety without causing sedation or the tolerance/dependence associated with classical benzodiazepines.
Enkephalin Stability
Inhibits enzymes that break down enkephalins (endogenous opioid peptides), extending their action and contributing to mood regulation effects.
Immune Modulation
Tuftsin-derived structure confers effects on NK cell activity, macrophage function, and cytokine balance — a mechanism distinct from its CNS effects.
BDNF & Serotonin Influence
Has demonstrated effects on BDNF levels and serotonin system modulation, contributing to cognitive and mood-regulatory properties beyond simple anxiolysis.
Preclinical and clinical models have investigated this compound across a wide range of physiological contexts and tissue types.
- Anxiety and generalized anxiety disorder models — primary Russian clinical application
- PTSD research — anxiolytic and stress-response modulation studies
- Cognitive function under stress — maintenance of performance during high-anxiety models
- Immune system modulation — NK cell activity and cytokine studies
- Depression models — overlap with Semax for combined mood and cognition research
- Addiction research — studies on alcohol withdrawal anxiety and opioid interaction
- Sleep quality — anxiolytic effects on sleep onset and architecture
Selank's combination of anxiolytic and immunomodulatory properties in a single compound makes it an unusual and versatile research tool.
Selank vs Semax is the most useful comparison for understanding the range of cognitive peptide research. Selank calms; Semax stimulates — they're complementary, not redundant.
| Aspect | Selank | Semax | Diazepam (reference) |
|---|---|---|---|
| Mechanism | GABA modulation, tuftsin analogue | BDNF upregulation, ACTH analogue | GABA-A positive allosteric modulator |
| Primary Effect | Anxiolytic, calming | Cognitive, mildly stimulating | Anxiolytic, sedating |
| Sedation | None | None | Significant |
| Dependence Risk | Not observed | Not observed | High |
| Research Use | Anxiety, PTSD, immune | Cognition, stroke, BDNF | Reference/comparator only |
The following reflects findings from published preclinical and clinical safety assessments where available.
No sedation or dependence observed in clinical use — cleaner anxiolytic profile than classical GABA modulators
Human clinical data available — Russian clinical history provides evidence base beyond typical Western research peptides
Dual mechanism — CNS anxiolytic + immune modulation in a single compound
Western data limited — not FDA approved; most detailed human data from Russian-language clinical literature
This overview is strictly educational and based on publicly available scientific literature as of 2026. It does not constitute medical advice. All Helixera Labs products are for laboratory research use only. Not for human or veterinary use. · Helixera Labs LLC © 2026